You have 9 free searches left this month | for more free features.

d-tace

Showing 1 - 2 of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)

Not yet recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • (no location specified)
Feb 17, 2023

Unresectable Hepatocellular Carcinoma Trial in Nanchang (D-TACE, HAIC, Lenvatinib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • D-TACE
  • +3 more
  • Nanchang, Jiangxi, China
    The Second Affiliated Hospital of Nanchang University
Oct 14, 2022